News

If you tuned into Woman's Hour on BBC Radio 4 this morning, you would have heard one of our Consultant Neurologists, Dr Simona Balestrini, discussing how Epilepsy Society's new €2.5 million genomics research partnership with biopharmaceutical UCB, could bring new hope to people with epilepsy.

A pioneering new approach being trialled at University College London Hospital (UCLH) hopes to make epilepsy surgery safer and easier. A team of researchers, clinicians and engineers from Epilepsy Society, UCLH, UCL and King’s College London have developed a world-leading software system called EpiNav, which stands for epilepsy navigation, and their work is being featured on today’s episode (10 October 2018) of the BBC’s Trust Me I’m a Doctor.

A decision by the Competition and Markets Authority to fine Pfizer and Flynn Pharma a total of £90m for overcharging for an epilepsy drug, has been remitted back to the CMA after a tribunal ruled against the government watchdog's decision.

New measures announced to stop babies being exposed to valproate in the womb Valproate medicines are available in the UK under brand names such as Epilim, Epival, Episenta, Convulex and Orlept No girl or woman should stop taking valproate without first consulting her doctor.

Epilepsy Society's chief executive Clare Pelham has joined the Sodium Valproate Expert Working Group which supports the Government's Commission on Human Medicines.

Epilepsy Society's chief executive, Clare Pelham, has welcomed a second letter from the Department of Health in response to her letter to health secretary Jeremy Hunt, calling for mandatory reviews for women and girls of childbearing age taking sodium valproate.